Paeonol inhibits the development of oral squamous cell carcinoma through the PI3K/AKT signaling pathway
Frontiers in Cell and Developmental Biology · 04.03.2026 · 14
DOI: 10.3389/fcell.2026.1747424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 04.03.2026. Verfasst von Changyue Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology,Affiliated Hospital of North Sichuan Medical College, Nanchong, China. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Paeonol (Pae), a phenolic bioactive compound extracted from Cortex Moutan, exhibits numerous pharmacological properties, including anti-inflammatory, immunomodulatory, and antitumor activities. However, the precise mechanisms by which Pae influences protective autophagy in oral squamous cell carcinoma (OSCC) remain incompletely characterized.
Methods
This study assessed the effects of Pae treatment on proliferation, migration, and invasive potential of OSCC cells in vitro . Network pharmacology was employed to identify potential molecular targets of Pae involved in OSCC. Autophagic flux was analyzed using transmission electron microscopy alongside a dual-fluorescence reporter assay. Additionally, the combined effects of Pae with autophagy inhibitors were investigated.
Results
Pae treatment promoted mitochondrial-dependent apoptosis and effectively inhibited epithelial–mesenchymal transition (EMT) by attenuating phosphorylation within the PI3K/AKT signaling pathway. Pae simultaneously initiated protective autophagy, confirmed by intact autophagic flux observed in CAL-27 and HSC-3 cells. Interference with this autophagic process through the autophagy inhibitor 3-methyladenine (3-MA) intensified apoptotic activity and markedly reduced OSCC cell proliferation.
Conclusion
Pae suppressed OSCC cell proliferation and EMT and was associated with mitochondrial apoptosis and activation of autophagic flux, accompanied by reduced PI3K/AKT phosphorylation. Co-treatment with 3-methyladenine (3-MA) further decreased cell viability and enhanced apoptosis-associated changes, suggesting that pharmacological co-targeting of PI3K signaling and autophagy may potentiate Pae’s antitumor activity. Further studies are warranted to delineate the relative contributions of apoptosis and autophagy to Pae-induced cytotoxicity in OSCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Stomatology,Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
- Department of Stomatology,North Sichuan Medical College, Nanchong, China.
- Jiangxi Provincial Key Laboratory of Oral Diseases, Department of Stomatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Department of Stomatology,Changsha Medical University, Changsha, China.
Zitieren
APA
Liu, C., Mou, X., Liu, J., Wu, Y., Han, J., Li, R., Gao, Y., & Liu, Y. (2026). Paeonol inhibits the development of oral squamous cell carcinoma through the PI3K/AKT signaling pathway. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1747424
Vancouver
Liu C, Mou X, Liu J, Wu Y, Han J, Li R, et al. Paeonol inhibits the development of oral squamous cell carcinoma through the PI3K/AKT signaling pathway. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1747424
BibTeX
@article{Liu2026,
author = {Liu, Changyue and Mou, Xuelin and Liu, Jiaming and Wu, Yuehan and Han, Jinpeng and Li, Ren and Gao, Yuxia and Liu, Ying},
title = {Paeonol inhibits the development of oral squamous cell carcinoma through the PI3K/AKT signaling pathway},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1747424}
}
EUVIMED